Stock Events

Stock Events

Regeneron Pharmaceuticals (REGN) Q2 2026 Earnings

29AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

8.43

9.92

11.4

12.89

Details

Expected EPS

8.913669

Actual EPS

9.47

Surprise EPS

0.56

Surprise Percent

+6.24%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 9.47 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.